[PD-1抑制剂增强化疗药物对Raji细胞系杀伤活性的研究] - Suppr

Suppr

超能文献

[Study on enhancing the killing activity of chemotherapy drugs by PD-1 inhibitor on Raji cell line].

作者信息

Zhang R, Li X, Li Z, Jiang Y Y, Ma L, Zhao M F, Deng Q

机构信息

Department of Hematology, Tianjin First Central Hospital, Tianjin 300192, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):76-79. doi: 10.3760/cma.j.issn.0253-2727.2020.01.015.

DOI:10.3760/cma.j.issn.0253-2727.2020.01.015

PMID:32023760

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7357903/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b2/7357903/3cccd1d6b186/cjh-41-01-076-g001.jpg

相似文献

[Study on enhancing the killing activity of chemotherapy drugs by PD-1 inhibitor on Raji cell line].[PD-1抑制剂增强化疗药物对Raji细胞系杀伤活性的研究]

Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):76-79. doi: 10.3760/cma.j.issn.0253-2727.2020.01.015.

[Regulatory Mechanism of Mangiferin Combined with Bortezomib on Malignant Biological Behavior of Burkitt Lymphoma and Its Effect on Expression of CXC Chemokine Receptors].芒果苷联合硼替佐米对伯基特淋巴瘤恶性生物学行为的调控机制及其对CXC趋化因子受体表达的影响

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Oct;31(5):1394-1402. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.022.

[Effects of Emodin Derivative on Cell Cycle, Apoptosis and NF-κB Pathway in Burkitt Lymphoma Cells].[大黄素衍生物对伯基特淋巴瘤细胞周期、凋亡及核因子κB通路的影响]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):474-488. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.027.

Hydrogen peroxide in the Burkitt's lymphoma cell line Raji provides protection against arsenic trioxide-induced apoptosis via the phosphoinositide-3 kinase signalling pathway.伯基特淋巴瘤细胞系Raji中的过氧化氢通过磷脂酰肌醇-3激酶信号通路提供对三氧化二砷诱导的细胞凋亡的保护作用。

Br J Haematol. 2004 May;125(4):512-20. doi: 10.1111/j.1365-2141.2004.04940.x.

[Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line].[NVP-BEZ235对伯基特淋巴瘤RAJI细胞系阿霉素耐药的逆转作用]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):476-482. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.024.

OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.OCT4 和 SOX2 特异性细胞毒性 T 淋巴细胞加程序性细胞死亡蛋白 1 抑制剂在体外杀伤肺癌干细胞样细胞和体内治疗耐药性肺癌小鼠方面表现出协同作用。

J Cell Physiol. 2019 May;234(5):6758-6768. doi: 10.1002/jcp.27423. Epub 2018 Nov 1.

[Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].[mTOR抑制剂雷帕霉素对伯基特淋巴瘤细胞的影响]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1397-1405. doi: 10.7534/j.issn.1009-2137.2017.05.020.

Research on the relationship between artesunate and Raji cell autophagy and apoptosis of Burkitt's lymphoma and its mechanism.青蒿琥酯对 Burkitt's 淋巴瘤 Raji 细胞自噬和凋亡关系及其机制的研究。

Eur Rev Med Pharmacol Sci. 2017 May;21(9):2238-2243.

[Apoptosis of Burkitt's lymphoma Raji cell line induced by bortezomib].硼替佐米诱导伯基特淋巴瘤Raji细胞系凋亡

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):592-6.

Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells.跨膜肿瘤坏死因子-α介导“正向”和“反向”信号传导，通过Raji伯基特淋巴瘤细胞中的核因子-κB途径诱导细胞死亡或存活。

J Leukoc Biol. 2008 Sep;84(3):789-97. doi: 10.1189/jlb.0208078. Epub 2008 Jun 11.

本文引用的文献

Effect and changes in PD‑1 expression of CD19 CAR‑T cells from T cells highly expressing PD‑1 combined with reduced‑dose PD‑1 inhibitor.高表达 PD-1 的 T 细胞来源的 CD19 CAR-T 细胞联合低剂量 PD-1 抑制剂后的效应及 PD-1 表达变化。

Oncol Rep. 2019 Jun;41(6):3455-3463. doi: 10.3892/or.2019.7096. Epub 2019 Apr 3.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.基线类固醇对非小细胞肺癌患者程序性细胞死亡-1 和程序性死亡配体 1 阻断疗效的影响。

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.帕博利珠单抗联合化疗治疗转移性非小细胞肺癌。

N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.

Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.针对 EBV 的细胞毒性反应与弥漫性大 B 细胞淋巴瘤的耐受微环境共存：临床特征和生存影响。

Sci Rep. 2017 Sep 7;7(1):10813. doi: 10.1038/s41598-017-11052-z.

Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.帕博利珠单抗治疗广泛期小细胞肺癌患者：来自 Ib 期 KEYNOTE-028 研究的结果。

J Clin Oncol. 2017 Dec 1;35(34):3823-3829. doi: 10.1200/JCO.2017.72.5069. Epub 2017 Aug 16.

CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma.CD274（程序性死亡配体1，PD-L1）/PDCD1（程序性死亡受体1，PD-1）在初发和转化型弥漫性大B细胞淋巴瘤中的表达

Br J Haematol. 2018 Mar;180(5):744-748. doi: 10.1111/bjh.14432. Epub 2016 Nov 23.

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer.研究免疫检查点抑制剂治疗非小细胞肺癌的临床试验

Rev Recent Clin Trials. 2016;11(4):297-305. doi: 10.2174/1574887111666160724181330.

Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.纳武利尤单抗联合铂类双药化疗用于晚期非小细胞肺癌的一线治疗

J Clin Oncol. 2016 Sep 1;34(25):2969-79. doi: 10.1200/JCO.2016.66.9861. Epub 2016 Jun 27.

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.GD2特异性嵌合抗原受体T细胞在遇到抗原后会经历强烈的激活和清除，但可通过程序性死亡蛋白1（PD-1）阻断来保护其免受激活诱导的细胞死亡。

Mol Ther. 2016 Jun;24(6):1135-1149. doi: 10.1038/mt.2016.63. Epub 2016 Mar 29.

Anti program death-1/anti program death-ligand 1 in digestive cancers.消化系统癌症中的抗程序性死亡-1/抗程序性死亡配体1

World J Gastrointest Oncol. 2015 Aug 15;7(8):95-101. doi: 10.4251/wjgo.v7.i8.95.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验